The Smith Group specializes in developing technologies for the minimally-invasive detection of diseases and illnesses, relevant towards women’s health, mental illness, and continued wellbeing. Our research is founded in the tenants of global health, where creating affordable and available diagnostics requires low cost and high quality.
Our point-of-care devices are now being developed, alongside a solid team of experts, to directly address current needs in primary and tertiary care settings. Through our research, we aim to create clinically driven, realistic, and useful prototypes. Our long-term goal is the translation of these concepts into useful products; for large-scale, global deployment.